Список литературы

Основные статьи

Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13:752-761.Аннотация external link opens in a new window

Shehata MM, Gomaa MR, Ali MA, et al. Middle East respiratory syndrome coronavirus: a comprehensive review. Front Med. 2016;10:120-136.Аннотация external link opens in a new window

Alraddadi BM, Watson JT, Almarashi A, et al. Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014. Emerg Infect Dis. 2016;22:49-55.Полный текст external link opens in a new windowАннотация external link opens in a new window

Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet. 2015;386:995-1007.Полный текст external link opens in a new windowАннотация external link opens in a new window

World Health Organization. Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected. Interim guidance. July 2015 [internet publication].Полный текст external link opens in a new window

Chong YP, Song JY, Seo YB, et al. Antiviral treatment guidelines for Middle East respiratory syndrome. Infect Chemother. 2015;47:212-222.Полный текст external link opens in a new windowАннотация external link opens in a new window

Статьи, указанные как источники

1. Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814-1820.Полный текст external link opens in a new windowАннотация external link opens in a new window

2. Raj VS, Osterhaus AD, Fouchier RA, et al. MERS: emergence of a novel human coronavirus. Curr Opin Virol. 2014;5:58-62.Полный текст external link opens in a new windowАннотация external link opens in a new window

3. Chan JF, Lau SK, To KK, et al. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev. 2015;28:465-522.Аннотация external link opens in a new window

4. WHO MERS-CoV Research Group. State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans. PLoS Curr. 2013;5.Полный текст external link opens in a new windowАннотация external link opens in a new window

5. Shalhoub S, Farahat F, Al-Jiffri A, et al. IFN-alpha-2a or IFN-beta-1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study. J Antimicrob Chemother. 2015;70:2129-2132.Аннотация external link opens in a new window

6. Oboho IK, Tomczyk SM, Al-Asmari AM, et al. 2014 MERS-CoV outbreak in Jeddah - a link to health care facilities. N Engl J Med. 2015;372:846-854.Полный текст external link opens in a new windowАннотация external link opens in a new window

7. Assiri A, McGeer A, Perl TM, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med. 2013;369:407-416.Полный текст external link opens in a new windowАннотация external link opens in a new window

8. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13:752-761.Аннотация external link opens in a new window

9. Al-Tawfiq JA, Hinedi K, Ghandour J, et al. Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients. Clin Infect Dis. 2014;59:160-165.Полный текст external link opens in a new windowАннотация external link opens in a new window

10. Memish ZA, Zumla AI, Assiri A. Middle East respiratory syndrome coronavirus infections in health care workers. N Engl J Med. 2013;369:884-886.Полный текст external link opens in a new windowАннотация external link opens in a new window

11. Amer H, Alqahtani AS, Alzoman H, et al. Unusual presentation of Middle East respiratory syndrome coronavirus leading to a large outbreak in Riyadh during 2017. Am J Infect Control. 2018 Apr 13. pii: S0196-6553(18)30146-9.Аннотация external link opens in a new window

12. Memish ZA, Al-Tawfiq JA, Assiri A, et al. Middle East respiratory syndrome coronavirus disease in children. Pediatr Infect Dis J. 2014;33:904-906.Аннотация external link opens in a new window

13. Khuri-Bulos N, Payne DC, Lu X, et al. Middle East respiratory syndrome coronavirus not detected in children hospitalized with acute respiratory illness in Amman, Jordan, March 2010 to September 2012. Clin Microbiol Infect. 2014;20:678-682.Полный текст external link opens in a new windowАннотация external link opens in a new window

14. Puzelli S, Azzi A, Santini MG, et al. Investigation of an imported case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Florence, Italy, May to June 2013. Euro Surveill. 2013;18:20564.Полный текст external link opens in a new windowАннотация external link opens in a new window

15. Kraaij-Dirkzwager M, Timen A, Dirksen K, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014. Euro Surveill. 2014;19:20817.Полный текст external link opens in a new windowАннотация external link opens in a new window

16. Guery B, Poissy J, el Mansouf L, et al. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission. Lancet. 2013;381:2265-2272.Аннотация external link opens in a new window

17. Abroug F, Slim A, Ouanes-Besbes L, et al. Family cluster of Middle East respiratory syndrome coronavirus infections, Tunisia, 2013. Emerg Infect Dis. 2014;20:1527-1530.Аннотация external link opens in a new window

18. Lee SI. Costly lessons from the 2015 Middle East respiratory syndrome coronavirus outbreak in Korea. J Prev Med Public Health. 2015;48:274-276.Полный текст external link opens in a new windowАннотация external link opens in a new window

19. Hui DS, Perlman S, Zumla A. Spread of MERS to South Korea and China. Lancet Respir Med. 2015;3:509-510.Аннотация external link opens in a new window

20. Ha KM. A lesson learned from the MERS outbreak in South Korea in 2015. J Hosp Infect. 2016;92:232-234.Аннотация external link opens in a new window

21. Centers for Disease Control and Prevention. MERS in the US. September 2017 [internet publication].Полный текст external link opens in a new window

22. Public Health England. MERS-CoV case in England. August 2018 [internet publication].Полный текст external link opens in a new window

23. World Health Organization. Disease outbreak news. Middle East respiratory syndrome coronavirus (MERS-CoV) infection – Republic of Korea. September 2018 [internet publication].Полный текст external link opens in a new window

24. World Health Organization. MERS situation update. August 2018 [internet publication].Полный текст external link opens in a new window

25. Omrani AS, Saad MM, Baig K, et al. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis. 2014;14:1090-1095.Аннотация external link opens in a new window

26. Saad M, Omrani AS, Baig K, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia. Int J Infect Dis. 2014;29:301-306.Полный текст external link opens in a new windowАннотация external link opens in a new window

27. Alenazi TH, Al Arbash H, El-Saed A, et al. Identified transmission dynamics of Middle East respiratory syndrome coronavirus infection during an outbreak: implications of an overcrowded emergency department. Clin Infect Dis. 2017;65:675-679.Аннотация external link opens in a new window

28. Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58:309-318.Полный текст external link opens in a new windowАннотация external link opens in a new window

29. Memish ZA, Zumla AI, Al-Hakeem RF, et al. Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med. 2013;368:2487-2494.Полный текст external link opens in a new windowАннотация external link opens in a new window

30. Omrani AS, Matin MA, Haddad Q, et al. A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case. Int J Infect Dis. 2013;17:e668-e672.Полный текст external link opens in a new windowАннотация external link opens in a new window

31. Memish ZA, Cotten M, Watson SJ, et al. Community case clusters of Middle East respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: a descriptive genomic study. Int J Infect Dis. 2014;23:63-68.Полный текст external link opens in a new windowАннотация external link opens in a new window

32. Al-Abdallat MM, Payne DC, Alqasrawi S, et al. Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description. Clin Infect Dis. 2014;59:1225-1233.Полный текст external link opens in a new windowАннотация external link opens in a new window

33. Shehata MM, Gomaa MR, Ali MA, et al. Middle East respiratory syndrome coronavirus: a comprehensive review. Front Med. 2016;10:120-136.Аннотация external link opens in a new window

34. van Boheemen S, de Graaf M, Lauber C, et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio. 2012;3:e00473-12.Полный текст external link opens in a new windowАннотация external link opens in a new window

35. Cotten M, Watson SJ, Zumla AI, et al. Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus. MBio. 2014;5:e01062-13.Полный текст external link opens in a new windowАннотация external link opens in a new window

36. Omrani AS, Shalhoub S. Middle East respiratory syndrome coronavirus (MERS-CoV): what lessons can we learn? J Hosp Infect. 2015;91:188-196.Аннотация external link opens in a new window

37. Reusken CB, Haagmans BL, Muller MA, et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis. 2013;13:859-866.Аннотация external link opens in a new window

38. Reusken CB, Ababneh M, Raj VS, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013. Euro Surveill. 2013;18:20662.Полный текст external link opens in a new windowАннотация external link opens in a new window

39. Perera RA, Wang P, Gomaa MR, et al. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. 2013;18:20574.Полный текст external link opens in a new windowАннотация external link opens in a new window

40. Muller MA, Corman VM, Jores J, et al. MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997. Emerg Infect Dis. 2014;20:2093-2095.Полный текст external link opens in a new windowАннотация external link opens in a new window

41. Meyer B, Muller MA, Corman VM, et al. Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis. 2014;20:552-559.Полный текст external link opens in a new windowАннотация external link opens in a new window

42. Hemida MG, Perera RA, Wang P, et al. Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013. Euro Surveill. 2013;18:20659.Полный текст external link opens in a new windowАннотация external link opens in a new window

43. Corman VM, Jores J, Meyer B, et al. Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992-2013. Emerg Infect Dis. 2014;20:1319-1322.Полный текст external link opens in a new windowАннотация external link opens in a new window

44. Alagaili AN, Briese T, Mishra N, et al. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio. 2014;5:e00884-14.Полный текст external link opens in a new windowАннотация external link opens in a new window

45. Alexandersen S, Kobinger GP, Soule G, et al. Middle East respiratory syndrome coronavirus antibody reactors among camels in Dubai, United Arab Emirates, in 2005. Transbound Emerg Dis. 2014;61:105-108.Полный текст external link opens in a new windowАннотация external link opens in a new window

46. Ferguson NM, Van Kerkhove MD. Identification of MERS-CoV in dromedary camels. Lancet Infect Dis. 2014;14:93-94.Аннотация external link opens in a new window

47. Hemida MG, Chu DK, Poon LL, et al. MERS coronavirus in dromedary camel herd, Saudi Arabia. Emerging Infect Dis. 2014;20:1231-1234.Полный текст external link opens in a new windowАннотация external link opens in a new window

48. Hemida MG, Elmoslemany A, Al-Hizab F, et al. Dromedary camels and the transmission of Middle East respiratory syndrome coronavirus (MERS-CoV). Transbound Emerg Dis. 2017;64:344-353.Аннотация external link opens in a new window

49. Hemida MG, Perera RA, Al Jassim RA, et al. Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. Euro Surveill. 2014;19:20828.Полный текст external link opens in a new windowАннотация external link opens in a new window

50. Nowotny N, Kolodziejek J. Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels, Oman, 2013. Euro Surveill. 2014;19:20781.Полный текст external link opens in a new windowАннотация external link opens in a new window

51. Yusof MF, Eltahir YM, Serhan WS, et al. Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Abu Dhabi Emirate, United Arab Emirates. Virus Genes. 2015;50:509-513.Аннотация external link opens in a new window

52. Farag EA, Reusken CB, Haagmans BL, et al. High proportion of MERS-CoV shedding dromedaries at slaughterhouse with a potential epidemiological link to human cases, Qatar 2014. Infect Ecol Epidemiol. 2015;5:28305.Полный текст external link opens in a new windowАннотация external link opens in a new window

53. Briese T, Mishra N, Jain K, et al. Middle East respiratory syndrome coronavirus quasispecies that include homologues of human isolates revealed through whole-genome analysis and virus cultured from dromedary camels in Saudi Arabia. MBio. 2014;5:e01146-14.Полный текст external link opens in a new windowАннотация external link opens in a new window

54. Adney DR, van Doremalen N, Brown VR, et al. Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels. Emerg Infect Dis. 2014;20:1999-2005.Полный текст external link opens in a new windowАннотация external link opens in a new window

55. Anthony SJ, Gilardi K, Menachery VD, et al. Further evidence for bats as the evolutionary source of Middle East respiratory syndrome coronavirus. MBio. 2017;8:e00373-17.Полный текст external link opens in a new windowАннотация external link opens in a new window

56. Haagmans BL, Al Dhahiry SH, Reusken CB, et al. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis. 2014;14:140-145.Аннотация external link opens in a new window

57. Al Hammadi AM, Chu DKW, Eltahir YM, et al. Asymptomatic MERS-CoV infection in humans possibly linked to infected dromedaries imported from Oman to United Arab Emirates, May 2015. Emerg Infect Dis. 2015;21:2197-2200.Полный текст external link opens in a new windowАннотация external link opens in a new window

58. Memish ZA, Cotten M, Meyer B, et al. Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. Emerg Infect Dis. 2014;20:1012-1015.Полный текст external link opens in a new windowАннотация external link opens in a new window

59. Azhar EI, El-Kafrawy SA, Farraj SA, et al. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med. 2014;370:2499-2505.Полный текст external link opens in a new windowАннотация external link opens in a new window

60. Hemida MG, Al-Naeem A, Perera RA, et al. Lack of Middle East respiratory syndrome coronavirus transmission from infected camels. Emerg Infect Dis. 2015;21:699-701.Полный текст external link opens in a new windowАннотация external link opens in a new window

61. Alraddadi BM, Watson JT, Almarashi A, et al. Risk factors for primary Middle East respiratory syndrome coronavirus illness in humans, Saudi Arabia, 2014. Emerg Infect Dis. 2016;22:49-55.Полный текст external link opens in a new windowАннотация external link opens in a new window

62. Kim SH, Chang SY, Sung M, et al. Extensive viable Middle East respiratory syndrome (MERS) coronavirus contamination in air and surrounding environment in MERS isolation wards. Clin Infect Dis. 2016;63:363-369.Полный текст external link opens in a new windowАннотация external link opens in a new window

63. Centers for Disease Control and Prevention. MERS clinical features. September 2017 [internet publication].Полный текст external link opens in a new window

64. Park HY, Lee EJ, Ryu YW, et al. Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Euro Surveill. 2015;20:21169.Полный текст external link opens in a new windowАннотация external link opens in a new window

65. van Doremalen N, Bushmaker T, Munster VJ. Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions. Euro Surveill. 2013;18:20590.Полный текст external link opens in a new windowАннотация external link opens in a new window

66. Bin SY, Heo JY, Song MS, et al. Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea. Clin Infect Dis. 2016;62:755-760.Аннотация external link opens in a new window

67. Cauchemez S, Van Kerkhove MD, Riley S, et al. Transmission scenarios for Middle East respiratory syndrome coronavirus (MERS-CoV) and how to tell them apart. Euro Surveill. 2013;18:20503.Полный текст external link opens in a new windowАннотация external link opens in a new window

68. Cauchemez S, Fraser C, Van Kerkhove MD, et al. Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis. 2014;14:50-56.Полный текст external link opens in a new windowАннотация external link opens in a new window

69. Breban R, Riou J, Fontanet A. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet. 2013;382:694-699.Аннотация external link opens in a new window

70. Zumla A, Hui DS. Infection control and MERS-CoV in health-care workers. Lancet. 2014;383:1869-1871.Аннотация external link opens in a new window

71. Raj VS, Mou H, Smits SL, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495:251-254.Аннотация external link opens in a new window

72. Belouzard S, Millet JK, Licitra BN, et al. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses. 2012;4:1011-1033.Полный текст external link opens in a new windowАннотация external link opens in a new window

73. Xia S, Liu Q, Wang Q, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein. Virus Res. 2014;194:200-210.Аннотация external link opens in a new window

74. Bosch BJ, Raj VS, Haagmans BL. Spiking the MERS-coronavirus receptor. Cell Res. 2013;23:1069-1070.Полный текст external link opens in a new windowАннотация external link opens in a new window

75. Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet. 2015;386:995-1007.Полный текст external link opens in a new windowАннотация external link opens in a new window

76. Reuss A, Litterst A, Drosten C, et al. Contact investigation for imported case of Middle East respiratory syndrome, Germany. Emerg Infect Dis. 2014;20:620-625.Полный текст external link opens in a new windowАннотация external link opens in a new window

77. Bialek SR, Allen D, Alvarado-Ramy F, et al. First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014. MMWR Morb Mortal Wkly Rep. 2014;63:431-436.Полный текст external link opens in a new windowАннотация external link opens in a new window

78. Arabi YM, Arifi AA, Balkhy HH, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med. 2014;160:389-397.Полный текст external link opens in a new windowАннотация external link opens in a new window

79. Deenitchina SS, Ando T, Okuda S, et al. Cellular immunity in hemodialysis patients: a quantitative analysis of immune cell subsets by flow cytometry. Am J Nephrol. 1995;15:57-65.Аннотация external link opens in a new window

80. Beigel JH, Voell J, Kumar P, et al. Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study. Lancet Infect Dis. 2018 Apr;18(4):410-418.Аннотация external link opens in a new window

81. World Health Organization. WHO target product profiles for MERS-CoV vaccines. May 2017 [internet publication].Полный текст external link opens in a new window

82. World Health Organization. Infection prevention and control during health care for probable or confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Interim guidance. June 2015 [internet publication].Полный текст external link opens in a new window

83. Centers for Disease Control and Prevention. Preventing MERS-CoV from spreading to others in homes and communities. September 2017 [internet publication].Полный текст external link opens in a new window

84. Hotez PJ, Bottazzi ME, Tseng C-T, et al. Calling for rapid development of a safe and effective MERS vaccine. Microbes Infect. 2014;16:529-531.Аннотация external link opens in a new window

85. Shalhoub S, Al-Zahrani A, Simhairi R, et al. Successful recovery of MERS CoV pneumonia in a patient with acquired immunodeficiency syndrome: a case report. J Clin Virol. 2015;62:69-71.Аннотация external link opens in a new window

86. Ministry of Health (Saudi Arabia). Middle East respiratory syndrome coronavirus; guidelines for healthcare professionals, version 5.1. May 2018 [internet publication].Полный текст external link opens in a new window

87. World Health Organization (WHO). Middle East respiratory syndrome coronavirus: case definition for reporting to WHO. July 2017 [internet publication].Полный текст external link opens in a new window

88. Centers for Disease Control and Prevention. Interim patient under investigation (PUI) guidance and case definitions. September 2017 [internet publication].Полный текст external link opens in a new window

89. World Health Organization. Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected. Interim guidance. July 2015 [internet publication].Полный текст external link opens in a new window

90. Memish ZA, Al-Tawfiq JA, Makhdoom HQ, et al. Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome. J Infect Dis. 2014;210:1590-1594.Полный текст external link opens in a new windowАннотация external link opens in a new window

91. World Health Organization. Laboratory testing for Middle East respiratory syndrome coronavirus. Interim guidance (revised). January 2018 [internet publication].Полный текст external link opens in a new window

92. Centers for Disease Control and Prevention. CDC laboratory testing for Middle East respiratory syndrome coronavirus (MERS-CoV). June 2018 [internet publication].Полный текст external link opens in a new window

93. Corman VM, Muller MA, Costabel U, et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. 2012;17:20334.Полный текст external link opens in a new windowАннотация external link opens in a new window

94. Ajlan AM, Ahyad RA, Jamjoom LG, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings. AJR Am J Roentgenol. 2014;203:782-787.Полный текст external link opens in a new windowАннотация external link opens in a new window

95. Corman VM, Eckerle I, Bleicker T, et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 2012;17:20285.Полный текст external link opens in a new windowАннотация external link opens in a new window

96. Hui DS, Memish ZA, Zumla A. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome. Curr Opin Pulm Med. 2014;20:233-241.Аннотация external link opens in a new window

97. Christian MD, Poutanen SM, Loutfy MR, et al. Severe acute respiratory syndrome. Clin Infect Dis. 2004;38:1420-1427.Полный текст external link opens in a new windowАннотация external link opens in a new window

98. Memish ZA, Al-Tawfiq JA, Makhdoom HQ, et al. Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study. Clin Microbiol Infect. 2014;20:469-474.Полный текст external link opens in a new windowАннотация external link opens in a new window

99. Drosten C, Meyer B, Muller MA, et al. Transmission of MERS-coronavirus in household contacts. N Engl J Med. 2014;371:828-835.Полный текст external link opens in a new windowАннотация external link opens in a new window

100. Raoult D, Charrel R, Gautret P, et al. From the Hajj: it's the flu, idiot. Clin Microbiol Infect. 2014;20:O1.Аннотация external link opens in a new window

101. Memish ZA, Assiri A, Almasri M, et al. Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the 2013 Hajj. J Infect Dis. 2014;210:1067-1072.Полный текст external link opens in a new windowАннотация external link opens in a new window

102. Gautret P, Charrel R, Benkouiten S, et al. Lack of MERS coronavirus but prevalence of influenza virus in French pilgrims after 2013 Hajj. Emerg Infect Dis. 2014;20:728-730.Полный текст external link opens in a new windowАннотация external link opens in a new window

103. Gautret P, Charrel R, Belhouchat K, et al. Lack of nasal carriage of novel corona virus (HCoV-EMC) in French Hajj pilgrims returning from the Hajj 2012, despite a high rate of respiratory symptoms. Clin Microbiol Infect. 2013;19:E315-E317.Полный текст external link opens in a new windowАннотация external link opens in a new window

104. Benkouiten S, Charrel R, Belhouchat K, et al. Circulation of respiratory viruses among pilgrims during the 2012 Hajj pilgrimage. Clin Infect Dis. 2013;57:992-1000.Полный текст external link opens in a new windowАннотация external link opens in a new window

105. Annan A, Owusu M, Marfo KS, et al. High prevalence of common respiratory viruses and no evidence of Middle East respiratory syndrome coronavirus in Hajj pilgrims returning to Ghana, 2013. Trop Med Int Health. 2015;20:807-812.Аннотация external link opens in a new window

106. World Health Organization. Management of asymptomatic persons who are RT-PCR positive for Middle East respiratory syndrome coronavirus (MERS-CoV). Interim guidance. January 2018 [internet publication].Полный текст external link opens in a new window

107. Al-Hameed F, Wahla AS, Siddiqui S, et al. Characteristics and outcomes of Middle East respiratory syndrome coronavirus patients admitted to an intensive care unit in Jeddah, Saudi Arabia. J Intensive Care Med. 2016;31:344-348.Аннотация external link opens in a new window

108. Alshahrani M, Sindi A, Alahmadi B, et al. Extracorporeal membrane oxygenation for severe MERS-CoV: a retrospective observational study. 46th critical care congress of the Society of Critical Care Medicine, United States 2016; abstract 958. Crit Care Med. 2016;44(12 Suppl 1):315.Полный текст external link opens in a new window

109. Arabi YM, Mandourah Y, Al-Hameed F, et al. Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome. Am J Respir Crit Care Med. 2018 Mar 15;197(6):757-767.Аннотация external link opens in a new window

110. World Health Organization. Home care for patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection presenting with mild symptoms and management of contacts. Interim guidance. June 2018 [internet publication].Полный текст external link opens in a new window

111. Centers for Disease Control and Prevention. Implementing home care and isolation or quarantine of people not requiring hospitalization for MERS-CoV. September 2017 [internet publication].Полный текст external link opens in a new window

112. Hart BJ, Dyall J, Postnikova E, et al. Interferon-beta and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays. J Gen Virol. 2014;95:571-577.Полный текст external link opens in a new windowАннотация external link opens in a new window

113. Chan JF, Chan KH, Kao RY, et al. Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J Infect. 2013;67:606-616.Аннотация external link opens in a new window

114. Chong YP, Song JY, Seo YB, et al. Antiviral treatment guidelines for Middle East respiratory syndrome. Infect Chemother. 2015;47:212-222.Полный текст external link opens in a new windowАннотация external link opens in a new window

115. Falzarano D, de Wit E, Martellaro C, et al. Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin. Sci Rep. 2013;3:1686.Полный текст external link opens in a new windowАннотация external link opens in a new window

116. Falzarano D, de Wit E, Rasmussen AL, et al. Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med. 2013;19:1313-1317.Полный текст external link opens in a new windowАннотация external link opens in a new window

117. Al-Tawfiq JA, Momattin H, Dib J, et al. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int J Infect Dis. 2014;20:42-46.Полный текст external link opens in a new windowАннотация external link opens in a new window

118. Khalid M, Al Rabiah F, Khan B, et al. Ribavirin and interferon (IFN)-alpha-2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus (MERS-CoV): a preliminary report of two cases. Antivir Ther. 2015;20:87-91.Аннотация external link opens in a new window

119. Al-Ghamdi M, Mushtaq F, Awn N, et al. MERS CoV infection in two renal transplant recipients: case report. Am J Transplant. 2015;15:1101-1104.Аннотация external link opens in a new window

120. Chu CM, Cheng VC, Hung IF, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59:252-256.Полный текст external link opens in a new windowАннотация external link opens in a new window

121. Chan JF, Yao Y, Yeung ML, et al. Treatment with lopinavir/ritonavir or interferon-beta1b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset. J Infect Dis. 2015;212:1904-1913.Аннотация external link opens in a new window

122. Spanakis N, Tsiodras S, Haagmans BL, et al. Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen. Int J Antimicrob Agents. 2014;44:528-532.Аннотация external link opens in a new window

123. US National Institutes of Health. ClinicalTrials.gov: MERS-CoV Infection tReated with A Combination of Lopinavir/ritonavir and interferon beta-1b (MIRACLE): a multicenter, placebo-controlled, double-blind randomized trial (trial id NCT02845843). November 2016 [internet publication].Полный текст external link opens in a new window

124. de Wilde AH, Raj VS, Oudshoorn D, et al. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-alpha treatment. J Gen Virol. 2013;94:1749-1760.Полный текст external link opens in a new windowАннотация external link opens in a new window

125. Pan Q, de Ruiter PE, Metselaar HJ, et al. Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo. Hepatology. 2012;55:1673-1683.Аннотация external link opens in a new window

126. Cheng KW, Cheng SC, Chen WY, et al. Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus. Antiviral Res. 2015;115:9-16.Аннотация external link opens in a new window

127. Mailles A, Blanckaert K, Chaud P, et al. First cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro Surveill. 2013;18:20502.Полный текст external link opens in a new windowАннотация external link opens in a new window

128. Mou H, Raj VS, van Kuppeveld FJ, et al. The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies. J Virol. 2013;87:9379-9383.Полный текст external link opens in a new windowАннотация external link opens in a new window

129. Du L, Zhao G, Yang Y, et al. A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein. J Virol. 2014;88:7045-7053.Полный текст external link opens in a new windowАннотация external link opens in a new window

130. Du L, Kou Z, Ma C, et al. A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines. PLoS One. 2013;8:e81587.Полный текст external link opens in a new windowАннотация external link opens in a new window

131. Ying T, Du L, Ju TW, et al. Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies. J Virol. 2014;88:7796-7805.Полный текст external link opens in a new windowАннотация external link opens in a new window

132. Tang XC, Agnihothram SS, Jiao Y, et al. Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution. Proc Natl Acad Sci USA. 2014;111:E2018-E2026.Полный текст external link opens in a new windowАннотация external link opens in a new window

133. Jiang L, Wang N, Zuo T, et al. Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein. Sci Transl Med. 2014;6:234ra59.Аннотация external link opens in a new window

134. Lu L, Liu Q, Zhu Y, et al. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat Commun. 2014;5:3067.Полный текст external link opens in a new windowАннотация external link opens in a new window

135. Channappanavar R, Lu L, Xia S, et al. Protective effect of intranasal regimens containing peptidic Middle East respiratory syndrome coronavirus fusion inhibitor against MERS-CoV infection. J Infect Dis. 2015;212:1894-1903.Аннотация external link opens in a new window

136. Fung HB, Guo Y. Enfuvirtide: a fusion inhibitor for the treatment of HIV infection. Clin Ther. 2004;26:352-378.Аннотация external link opens in a new window

137. Poissy J, Goffard A, Parmentier-Decrucq E, et al. Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases. J Clin Virol. 2014;61:275-278.Аннотация external link opens in a new window

138. Cha RH, Joh JS, Jeong I, et al. Renal complications and their prognosis in Korean patients with Middle East respiratory syndrome-coronavirus from the central MERS-CoV designated hospital. J Korean Med Sci. 2015;30:1807-1814.Полный текст external link opens in a new windowАннотация external link opens in a new window

139. Eckerle I, Muller MA, Kallies S, et al. In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East respiratory syndrome (MERS) coronavirus infection. Virol J. 2013;10:359.Полный текст external link opens in a new windowАннотация external link opens in a new window

Использование этого контента попадает под действие нашего заявления об отказе от ответственности